Murthy V. Simhambhatla, PhD, Abbott Medical Optics president, discusses pearls and pitfalls of milestone deals in a session he chaired at the Ophthalmology Futures European Forum in Amsterdam, preceding the ESCRS.
Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia
More than a million Americans suffer from hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma. People with hemianopia frequently bump into walls, trip over objects, or walk into people on the…
Safety and Tolerability of Ranibizumab in Mono/Bilateral w-AMD Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye
Status: Not yet recruiting,
Condition Summary: Wet Age Related Macular Degeneration
Drug-Induced Uveitis
What types of drugs, systemic or otherwise, are often associated with uveitis? This new study describes. Current Opinion in Ophthalmology
Generating an alternative to IVIG therapy: an interview with Professor Richard Pleass, LSTM
IVIG is a hugely successful biological with FDA approval for treating idiopathic thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, Graves ophthalmopathy and numerous polyneuropathies.
Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study – Corrected Proof
Objective: To determine whether home monitoring with the ForeseeHome device (Notal Vision Ltd, Tel Aviv, Israel), using macular visual field testing with hyperacuity techniques and telemonitoring, results in earlier detection of age-related macular deg…